Leronlimab Is Making A Comeback, Now, Better Than Ever

Greetings! Happy Thanksgiving 2022. Quick note: Leronlimab Times has exceeded 1,000 members and I felt that was a milestone worth mentioning. Welcome.

​

What drug is so influential, so polarizing, so relevant that a very wealthy individual David Welch, founding Partner of 4-good.com, put up $6.5M of his own money as a bond to back its effectiveness?

https://www.4-good.com/team-profile/dave-welch

​

Also, listed on page 7 of this S3 document, https://www.cytodyn.com/investors/sec-filings/all-sec-filings/content/0001558370-22-013907/0001558370-22-013907.pdf

​

this man and his company are at the top of the list owning nearly 4% of CytoDyn. Back in March, 2022 or so, Mr. Welch, just about saved CytoDyn and saved the case it is currently in with Amarex. His actions saved the aggregation of the raw data and will be deemed a necessary component to the ultimate lifting of the clinical hold. Without his actions, CytoDyn and Leronlimab would be in far, far more worse shape than it appears to be today.

David Welch knew exactly what he was doing when he provided that bond collateral. He understood the molecule sufficiently, and was aware of its capacity functioning as a CCR5 blockade while also holding the attribute of being safer than water at the same time. He knew of its saving characteristics. Therefore, he had no trouble standing so confidently behind it.

With his bond, CytoDyn became permitted and authorized to acquire the raw data and was allowed to perform an audit after the aggregation of that data. Following was a validation through an FDA Type GCP audit x3, which proved that Leronlimab is a safe and effective drug as per FDA GCP guidelines. That which was utter stolen from Cytoyn and from Leronlimab, Welch essentially returned back to CytoDyn and back to Leronlimab, that which was stolen from it and that was the chance to prove its safety and effectiveness. Welch returned back to CytoDyn exactly what the enemy in collusion with many partners, attempted to steal from CytoDyn, who were caught red handed, stealing, yet DW returned back the stolen goods to their rightful owner CytoDyn.

Soon, the FDA lifts the Clinical Hold; soon the FDA permits the use of Leronlimab in new trials; soon the NDAs are revealed and the Partnerships are disclosed; Soon the Amarex arbitration settles. The Trials emerge from the wreckage.

The results of the prior trials are to be built upon. We know how Leronlimab performs in HIV. We know how it performs in Covid. In mTNBC, in Long Haulers and in NASH. Based on its performance in these indications, New trials are designed with greater numbers of patients which will be run in accordance with FDA GCP guidelines. These trials shall go on to prove unequivocally, exactly what the efficacy of Leronliimab in each individual indication, exactly is, knowing that the validity of these trials was not in question. So then, these coming trials will deliver the final tallies on exactly what Leronlimab is capable of. They will provide the hard data and not just anecdotal data or information on the drug. And this is what David Welch put his $6.5 million on the line for. 4-good.

The truth about Leronlimab approaches on the horizon. Right now, we only speculate in part based on past evidence. But soon, we will know fully, the undeniable truth, the length, depth and width of the scope of the drug. The coming trials will change the paradigm of the masses. What the group think is on Leronlimab. Too many bashers keep bashing it because it doesn't have validated data backing it, data which proves statistical significance and where too much anecdotal information is used to describe the drug. The coming trials shall prove everything and nothing will be left up for speculation.

CytoDyn's Quality Chief ensures that each trial is run according to FDA Type GCP Guidelines. Ryan Dunlap ensures that CytoDyn is run clean as a whistle, and every audit that tests it against FDA GCP Guideline standards pass its audit. All of this begins when the hold is lifted. Partners are revealed. Amarex settles in the proximal future. Trials are conducted flawlessly because of what we have learned.

It is exactly the outcomes of these coming trials that the enemy desperately fears. They don't want to know what Leronlimab is factually capable of doing. They rise up together in unison, in opposition of the formation of these partnerships. They speak in one voice to oppose and protest the coming trials. As a whole, they fear the results of the Leronlimab trials. They call it dangerous. They say it is unnecessary. They say the data is forged. Anything and everything they do to keep the drug down, suppressed, out of "harms way", out of an "abundance of caution" as if it were some kind of horrible substance, dangerous, fatal even, with very harsh side effects. They reek. They drip with guilt. I smell their fear. I feel their fear. They don't want Leronlimab to return back. But, thanks to DW, it certainly will. David prevented this cabal from destroying Leronlimab's voice and from destroying Leronlimab's influence.

At the heart of it, Leronlimab really is their only threat. A threat to their agenda. A threat to their existence. They will slice it every way to Sunday but still not find anything wrong with it. Just like what they have already shown they are capable of in this clinical hold, they have found that the drug is safe and effective, but that the quality standards exhibited by the CRO Amarex did not meet the FDA Type GCP guideline standard mark. Leronlimab has already passed the investigations of safety and effectiveness. Thanks to the external auditor x3 saying so. David Welch was confident of this. The FDA was trying to put us away. They failed. Amarex was trying to put us away. They failed. 13D was trying to put us away. They failed. DW greatly helped CytoDyn. He succeeded. Leronlimab is making a comeback, now, better than ever.

You can't get rid of this molecule. It is too vital for humanity. For many, many, many years to come, it will not be matched. This is why he put up the $6.5 million without hesitation. If it were not so special, he would never have sunk the money in it. People will end up dying without the drug or they will have to deal with the uncertainty of life or the hardship of side effects. People will be unwilling to relinquish the drug. They will give up everything else, their money, their cars, their homes, but not the drug.

He is the single greatest proponent of this drug bar none. But all of us longs, march forward to the beat of the same drum, into the torrent. We longs shall persevere. We stand tall into the storms and in the end, we win.

We find ourselves at a great impasse. They say we are out. We say we aren't going anywhere. They want to convince everyone that Leronlimab is done, that it is a has been, a never do well. They know that when Leronlimab is put to the test, that it will singlehandedly beat any other drug they can muster up for the indications Leronlimab treats. Leronlimab is unveiled very soon. Leronliimab is to be revealed in the coming new trials.

It is not clear what the purpose was for this Pause. Why it was necessary for Leronlimab to slow down and to be defeated for these couple of years. Was it for the ingrafting of a multitude of believers to be indoctrinated as massive shareholders in the company? It is just not clear why. However, over time, we have come to know through these message boards, who it is that is with you and who it is that is against you. It is clear to me, that after studying these boards who are the David Welches of CytoDyn. We know where they stand. We don't have to wonder.

It was necessary for this Company to go through the depths of hell also to weed out the wicked. We needed to learn who needed to get out and we needed to bring in the new leadership. CytoDyn is still in the midst of this process but it started with Nader Pourhassan, when CytoDyn terminated their relationship with him. This taking a "step back" was necessary in CytoDyn's evolution to reveal what had to be revealed in order to make a great company from its bare skeleton. The depths of despair bring about the understanding and knowledge of who is with you and who is not.

Cyrus Arman has surrounded him self with an Independent Board. He knows where each Board Member stands. He gets the answers he is looking for and moves forward quickly. There is no red-tape. He doesn't need to "wonder", rather, he already knows the truth because there are no ulterior motives. Cyrus won't be misled. No games will be played with him. He won't have to deal with losers, or leeches, or spineless cockroaches. Since they are gone, and since he is of one mind with his current cabinet, Cyrus accomplishes that which he wants to accomplish, far, far easier. Cyrus is not compromised. He leads by his own ideals.

When it comes time to fight, Cyrus leads with a clear head. An advised head. An unwavering will, standing firm our ground, we shall win. December 7, CA makes his initial move and introduces his right rear flank. The plan of attack is made partially manifest. On December 9, he follows through and backs up and reinforces this first move. In response, it is delivered already planned. Cyrus is ready, his entire left flank remains available. He holds the reigns. He decides on his time, by his timing.

Happy Thanksgiving, thanks for your feedback and support and I give thanks for this opportunity. I pray for His blessing on it and upon all here invested for the success of this molecule.